Aortic Aneurysm: Symptoms, Diagnosis, Surgery, and Treatment

What is Aneurysm?

An aneurysm is a localized, abnormal dilation of an artery. Imagine a small balloon-like bulge forming along the wall of a blood vessel. Arteries are the blood vessels that carry oxygen-rich blood from the heart and lungs to the organs and tissues of the body. Their walls are normally thick, muscular, and elastic, designed to withstand the pulsatile pressure generated by each heartbeat.

However, certain medical conditions, genetic predispositions, and physical trauma can damage or weaken arterial walls over time. When a segment of arterial wall is weakened, the relentless mechanical force of blood pulsing through the vessel with every heartbeat can progressively push outward on that weak point, causing a bulge to form and expand over months or years. This bulge is the aneurysm.

The clinical danger of an aneurysm lies not in its presence per se, but in two catastrophic potential complications:

• Rupture: When the aneurysm grows large enough that the weakened wall can no longer contain the blood pressure, it bursts. This causes massive internal hemorrhage: a life-threatening emergency where blood pours into the body cavities at a rate that quickly overwhelms the body’s compensatory capacity. Ruptured aortic aneurysms are among the most lethal cardiovascular emergencies.

• Dissection: In aortic dissection the high-pressure blood does not immediately break through the outer wall. Instead, it forces its way into the wall itself, separating its inner and middle layers (the intima from the media) along a longitudinal plane. Blood fills and tracks along this “false channel” within the wall, expanding the dissection and potentially cutting off blood supply to major branches of the aorta that supply vital organs (including the kidneys, intestines, spinal cord, and legs). Both rupture and dissection can be rapidly fatal.

In the vast majority of patients, a simple aortic aneurysm causes no obvious symptoms. It grows silently, undetected, often for years. Only when it becomes very large and exerts pressure on adjacent structures might it cause:

• A pulsating sensation in the abdomen and/or back pain (in abdominal aortic aneurysms)
• Chest pain, back pain, hoarseness, cough, or shortness of breath (in thoracic aortic aneurysms)

The most common symptom of aneurysm rupture is sudden, severe abdominal pain, which represents an extreme medical emergency. Both rupture and dissection are frequently fatal. In contrast, the prognosis is good when an aneurysm is surgically corrected before it ruptures. Once an abdominal aortic aneurysm begins to tear or ruptures, only approximately 1 in 5 patients survives.

Critical advice:

• Consult your physician if you notice any pulsatile or non-pulsatile lump on your body, with or without pain.
• Call emergency services immediately (911 in the US, 999 in the UK) or go directly to the nearest emergency room if you experience sudden, intense, unexplained abdominal or back pain, particularly if it is persistent and accompanied by sweating, nausea, or a feeling of impending doom.

---

Anatomy Overview

The aorta is the largest and most important artery in the human body. It originates directly from the heart, specifically from the left ventricle (the main pumping chamber), and courses downward through the chest and abdomen. At the level of the pelvis, it divides into two major branches: the common iliac arteries, which supply the legs and pelvis. The aorta is therefore the trunk from which all systemic blood supply ultimately derives, carrying oxygenated blood to the head and neck, arms, chest organs, abdominal organs (kidneys, liver, spleen, intestines), and lower limbs.

The aorta is anatomically divided into several segments by its location:

• Ascending aorta: Rises from the heart, giving off the coronary arteries that supply the heart muscle.
• Aortic arch: Curves over the heart, giving off branches to the head, neck, and arms (brachiocephalic trunk, left common carotid, and left subclavian arteries).
• Descending thoracic aorta: Descends through the chest cavity behind the heart and lungs.
• Abdominal aorta: Continues below the diaphragm (the breathing muscle), giving off branches to the kidneys, intestines, and other abdominal organs, before dividing into the iliac arteries.

For clinical purposes, aneurysms of the aorta are classified based on their anatomical location:

Abdominal Aortic Aneurysms (AAA)

An aneurysm affecting the portion of the aorta below the diaphragm is called an abdominal aortic aneurysm (AAA). The vast majority of aortic aneurysms, approximately 75%, are of this type. Most are located just below the origin of the renal arteries (infrarenal AAA), which is the most common anatomical variant. AAA is the most clinically significant aortic aneurysm in terms of population-level disease burden.

Small AAAs rarely rupture, and many can grow to considerable size without producing any symptoms. The increasing use of CT scanning for other medical indications has led to a substantially higher incidental detection rate of AAA compared to previous decades. Regular monitoring and, when indicated, timely intervention can prevent growth and rupture.

Thoracic Aortic Aneurysms (TAA)

An aneurysm affecting the portion of the aorta above the diaphragm in the chest cavity is called a thoracic aortic aneurysm (TAA). These aneurysms may involve the ascending aorta, the aortic arch, or the descending thoracic aorta.

Thoracic aneurysms do not always cause symptoms, even when large. Only approximately half of all patients with TAA develop any symptoms. As with AAA, their incidental detection has increased with the widespread use of CT scanning.

In the most common type of TAA, the ascending aorta near the heart dilates progressively. This dilation can stretch the aortic valve annulus, preventing the aortic valve from closing completely and causing aortic regurgitation: blood leaks backward into the heart with each beat, imposing a progressive volume overload on the left ventricle.

A less common type of TAA develops in the upper descending thoracic aorta, distal to the aortic arch. This type is more frequently associated with trauma (e.g., from motor vehicle accidents involving rapid deceleration) and tends to occur in a younger population than aneurysms arising from degenerative disease.

Some patients develop thoracoabdominal aneurysms, extensive aneurysms that span both the thoracic and abdominal segments of the aorta. These represent the most complex anatomical variant to manage surgically.

---

Causes

The fundamental mechanism behind aneurysm formation is the combination of chronic mechanical stress from blood pressure against arterial walls and structural weakness or damage of the arterial wall itself. When the structural integrity of the aortic wall is compromised, pulsatile blood pressure gradually stretches the weakened segment outward, creating the aneurysmal dilation.

The most common underlying pathological processes contributing to aortic wall weakening include:

• Atherosclerosis (arteriosclerosis): The most common cause of AAA. Chronic inflammation, lipid deposition, and calcification within the arterial wall, which are hallmarks of atherosclerotic disease, progressively damage the medial layer of the aortic wall, reducing its elasticity and structural strength.

• Cystic medial necrosis: A degenerative process in which the elastic fibers and smooth muscle cells of the aortic media (the middle layer) are lost and replaced by cystic spaces filled with mucoid material. This is the predominant pathological substrate for aneurysms associated with connective tissue disorders and is particularly important in TAA.

• Inflammatory and infectious causes (rare): Rarely, systemic inflammatory conditions, such as vasculitis (which are inflammatory diseases of blood vessels), or untreated chronic infections (notably syphilis), a sexually transmitted disease caused by Treponema pallidum, can cause aortic aneurysms. Syphilitic aortitis, historically a major cause of ascending aortic aneurysms, is now rare but should be considered in appropriate epidemiological contexts. Other infections (mycotic aneurysms) may arise from bacteremia seeding a pre-existing atherosclerotic plaque.

• Genetic and hereditary connective tissue disorders: Certain inherited conditions cause abnormal structural proteins in the aortic wall, predisposing to aneurysm formation at younger ages and with higher rupture risk:

  • Marfan syndrome: An autosomal dominant disorder caused by mutations in the FBN1 gene (encoding fibrillin-1, a critical component of elastic fibers). Marfan syndrome typically causes dilation of the aortic root and ascending aorta, often beginning in young adulthood.
  • Loeys-Dietz syndrome: Caused by mutations in TGF-β receptor genes (TGFBR1 or TGFBR2). Associated with particularly aggressive aneurysm growth and high risk of dissection at smaller diameters than in Marfan syndrome.
  • Vascular Ehlers-Danlos syndrome (vEDS): Caused by mutations in COL3A1 (encoding type III collagen). Characterized by extreme fragility of arterial walls, with a very high risk of spontaneous rupture, often without substantial aneurysmal dilation preceding it.
  • Turner syndrome: A chromosomal condition (45,X0) in which cardiovascular abnormalities, including bicuspid aortic valve and aortic coarctation, are common and associated with increased aortic aneurysm risk.

• Bicuspid aortic valve (BAV): The most common congenital heart defect, occurring in approximately 1–2% of the general population. A bicuspid aortic valve has two leaflets instead of the normal three. Beyond the valve abnormality itself, BAV is associated with intrinsic abnormalities of the aortic wall structure, predisposing patients to progressive dilation of the ascending aorta independent of the degree of valvular dysfunction.

• Family history of aortic aneurysm: Multiple genes, beyond those causing named syndromes, contribute to aortic aneurysm susceptibility. A first-degree relative with AAA increases an individual’s risk by approximately 4-fold, and the genetic contribution to isolated AAA (without a named syndrome) is well established, though complex and polygenic.

• Physical trauma: Blunt chest trauma, particularly from high-speed deceleration injuries (such as motor vehicle accidents or falls from height), can cause traumatic aortic injury. This most commonly occurs at the aortic isthmus, which is the junction of the aortic arch and the descending thoracic aorta. It is a relatively fixed point where shear forces are concentrated. This can cause acute aortic transection or, if the injury is incomplete, a pseudo-aneurysm that may enlarge over time.

Risk Factors

Several well-established factors significantly increase the risk of developing an aortic aneurysm:

• Male sex: Aortic aneurysms are substantially more common in men than in women. AAA is approximately 4–6 times more frequent in men. However, when women do develop AAA, they are at higher risk of rupture at smaller diameters than men, which is a clinically important difference that influences screening and treatment decisions.

• Advanced age: The risk of AAA increases dramatically with age. The condition is most prevalent in individuals aged 65 years and older, as the cumulative effects of atherosclerosis, chronic hypertension, and tissue aging gradually weaken the aortic wall over decades. Routine screening is targeted primarily at this age group.

• Cigarette smoking: Tobacco smoking is the single most powerful modifiable risk factor for AAA. Smoking damages the aortic wall through direct toxic effects of tobacco compounds on elastin and collagen, through promotion of oxidative stress and inflammation in the aortic media, and through exacerbation of atherosclerosis. The duration of smoking history (pack-years) is directly correlated with AAA risk. Critically, even former smokers retain elevated risk for many years after cessation, though the risk gradually declines.

• Family history of aortic aneurysm: First-degree relatives of individuals with AAA (parents, siblings, children) have a substantially elevated risk of developing the condition. Family history-based screening is therefore recommended for at-risk relatives.

• History of peripheral artery aneurysm: Individuals who have developed aneurysms in the arteries of the legs (e.g., popliteal or femoral artery aneurysms) have a higher likelihood of harboring concurrent aortic aneurysms.

• Arterial hypertension (high blood pressure): Chronically elevated blood pressure imposes increased mechanical stress on the aortic wall at each heartbeat, accelerating degenerative changes and potentially contributing to aneurysm growth once an aneurysm has formed.

• Atherosclerosis: Generalized atherosclerotic disease, reflected by conditions such as coronary artery disease, peripheral artery disease, or carotid artery disease, is a strong risk factor for AAA. This is consistent with the shared underlying pathological process.

• Bicuspid aortic valve: Increases the risk of ascending aortic dilation and TAA (see above).

• Genetic syndromes: As described in the Causes section, Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, Turner syndrome, and related conditions substantially increase TAA risk and may cause aneurysms in younger individuals.

• Trauma: Motor vehicle accidents and other mechanisms of blunt chest trauma are relevant risk factors for acute aortic injury and subsequent aneurysm formation in the descending thoracic aorta.

---

Symptoms

One of the most clinically challenging and dangerous features of aortic aneurysms is that they can develop and grow for years without causing any signs or symptoms. In many patients, the aneurysm remains completely silent until it reaches a critical size, causes complications, or is discovered incidentally during imaging for another condition.

When symptoms do occur, they depend on the type (AAA vs. TAA), the size of the aneurysm, whether it is causing compression of adjacent structures, and, most critically, whether a rupture or dissection has occurred.

Abdominal Aortic Aneurysms

The majority of AAAs develop slowly over many years, characteristically described as “the silent killer” because of their ability to grow to dangerous sizes without warning. The aneurysm may be detected by a physician as a pulsatile abdominal mass during routine physical examination. This presents as a firm, expansile, pulsatile bulge palpable in the central abdomen, sometimes described as feeling like a “second heartbeat” in the belly.

When symptomatic (before rupture), AAA may cause:

• A noticeable pulsating sensation in the abdomen: patients may describe feeling their own heartbeat in their belly more prominently than usual
• Deep, aching pain in the back or flank, often in the region between the shoulder blades and the hips
• A persistent, nagging abdominal ache that may last for hours or days and does not resolve with simple measures

These symptoms, particularly back or abdominal pain in a patient with known or suspected risk factors for AAA, must be taken very seriously and warrant urgent medical evaluation, as they may indicate rapid aneurysm expansion, which is a precursor to rupture.

When an AAA ruptures, it causes:

• Sudden, intense, severe pain in the lower abdomen and back, often described as the worst pain the patient has ever experienced. It may radiate to the groin or thighs.
• Nausea and vomiting.
• Constipation and urinary problems: due to peri-aortic hematoma compressing adjacent structures
• Diaphoresis (profuse sweating)
• Confusion and altered consciousness resulting from hemorrhagic shock and cerebral hypoperfusion.
• Tachycardia (rapid pulse), particularly on standing from a sitting or lying position.

Hemorrhagic shock is the life-threatening consequence of massive internal blood loss from a ruptured AAA. It causes blood pressure to fall catastrophically, depriving the brain, kidneys, heart, and other vital organs of adequate perfusion. Without immediate surgical intervention, death follows rapidly. Even with emergency surgery, the mortality rate for ruptured AAA remains extremely high.

Important warning: In individuals with known or suspected AAA (or those with significant risk factors), the onset of sudden, severe abdominal or back pain constitutes a medical emergency requiring immediate activation of emergency services and transport to the nearest hospital capable of emergency vascular surgery.

Thoracic Aortic Aneurysms

Thoracic aortic aneurysms can also remain asymptomatic for many years. Again, they are often discovered incidentally on chest imaging performed for other reasons. As noted, only approximately 50% of TAA patients develop any symptoms.

When symptomatic (before rupture or dissection), TAA may cause:

• Pain: In the jaw, neck, upper back, or chest; the character and distribution of pain vary by aneurysm location. Ascending aortic aneurysms more commonly cause chest pain or pressure; descending thoracic aneurysms more commonly cause back pain.
• Cough and/or hoarseness: Caused by compression of the left recurrent laryngeal nerve (which loops under the aortic arch) or the tracheobronchial tree by a large aneurysm.
• Breathlessness and difficulty breathing (dyspnea): From compression of the trachea or bronchi by a large aneurysm.
• Difficulty swallowing (dysphagia): From esophageal compression.
• Aortic regurgitation murmur: In ascending aortic aneurysms that dilate the aortic root, backflow of blood through the incompetent aortic valve causes a characteristic diastolic murmur detectable on cardiac auscultation.

In the event of rupture or dissection, TAA causes:

• Sudden, excruciating pain, often described as “tearing” or “ripping”, typically begins in the upper back and radiates downward toward the abdomen. This is the classic presentation of aortic dissection and is one of the most severe pain experiences in clinical medicine.
• Pain may also be felt in the chest and arms.
• Rapid onset of shock, with severe hypotension, diaphoresis, and loss of consciousness.
• End-organ ischemia: Depending on which aortic branches are compromised by the dissection flap or by rupture, patients may present with stroke, paraplegia (from spinal cord ischemia), acute renal failure, intestinal ischemia, or acute limb ischemia.

Aortic dissection is a true medical emergency. If symptoms consistent with TAA dissection occur, particularly the sudden onset of severe, tearing chest or back pain, call emergency services immediately. Without prompt surgical or endovascular intervention, the condition is usually rapidly fatal.

---

Diagnosis

An aneurysm may be discovered during a routine physical examination when a physician palpates the abdomen and identifies a pulsatile mass. During auscultation of the abdomen with a stethoscope, the physician may detect a bruit (an abnormal whooshing or rushing sound) instead of the normal soft murmur of aortic flow, reflecting turbulent blood flow within the aneurysmal segment.

However, physical examination alone has limited sensitivity for detecting smaller AAAs, and TAA is generally not detectable on physical examination. Particularly in overweight or obese patients, an abdominal aneurysm may not be palpable even when large.

More commonly, aortic aneurysms are discovered incidentally during imaging performed for unrelated complaints, such as chest pain, abdominal pain, or routine health checks. They may also be detected through dedicated screening programs in high-risk individuals.

Medical Specialties Involved

The diagnosis and management of aortic aneurysms involves collaboration between several specialist disciplines:

• Vascular surgeon: Specializes in diseases of blood vessels throughout the body (excluding the heart and intracranial vessels). Vascular surgeons perform both open surgical repair and endovascular treatment of AAA and descending thoracic aortic aneurysms.
• Cardiothoracic surgeon: Specializes in surgery of the heart, lungs, and other thoracic structures, including the ascending aorta, aortic arch, and proximal descending thoracic aorta. When aortic valve repair is required alongside aneurysm surgery, a cardiothoracic surgeon performs the combined procedure.
• Interventional radiologist: May perform image-guided endovascular procedures for aortic aneurysms.
• Cardiologist: Involved in the medical management of risk factors and in echocardiographic evaluation, particularly for ascending aortic aneurysms and associated valve disease.
• General practitioner (primary care physician): The entry point for initial suspicion, referral, and long-term follow-up monitoring of patients with known aneurysms.
• Clinical geneticist: Essential for evaluation and counseling of patients with suspected hereditary connective tissue disorders (Marfan syndrome, Loeys-Dietz syndrome, vEDS) and their families.

Diagnostic Procedures and Tests

Several imaging modalities are used to detect, characterize, and monitor aortic aneurysms:

• Ultrasound (sonography) and echocardiography: Non-invasive, painless, radiation-free, and widely available. Ultrasound uses high-frequency sound waves to generate real-time images of internal structures. Abdominal ultrasound is the standard screening test for AAA; it can accurately measure the maximum aortic diameter and track changes over time. Echocardiography (cardiac ultrasound), particularly transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE), is used to evaluate the ascending aorta and aortic root. This is especially important in patients with suspected connective tissue disorders or bicuspid aortic valve.

• Computed Tomography (CT scan): The most important imaging modality for comprehensive aortic aneurysm evaluation. CT scanning uses X-rays from multiple angles to generate detailed cross-sectional images of the body. CT angiography (CTA), performed with intravenous contrast injection, provides the definitive assessment of aneurysm morphology, including:

  • Precise measurement of maximum aneurysm diameter and length
  • Relationship of the aneurysm to adjacent arterial branches (critical for surgical planning)
  • Detection of intraluminal thrombus (clot within the aneurysm sac)
  • Assessment of access vessels for endovascular planning
  • Detection of concurrent aneurysms elsewhere CTA images are significantly more detailed and anatomically precise than ultrasound, making them essential for pre-operative planning. The main limitations are radiation exposure and the need for iodinated contrast (which may be problematic in patients with renal impairment or contrast allergy).

• Magnetic Resonance Imaging (MRI): Uses magnetic fields and radio waves to generate detailed images without ionizing radiation. MRI and MR angiography (MRA) are excellent for evaluating aneurysm location, dimensions, and relationship to surrounding structures. Particularly useful as an alternative to CTA in patients who cannot receive iodinated contrast. However, MRI is slower, more expensive, and less immediately available than CT, making it less suitable in emergency settings.

• Angiography (conventional catheter angiography): Angiography involves inserting a thin catheter into an artery (usually the femoral artery in the groin), advancing it to the area of interest, and injecting iodinated contrast directly while acquiring X-ray images. This technique provides detailed visualization of the arterial lumen (the channel through which blood flows) and any associated stenoses or occlusions. While conventional angiography has been largely superseded by CTA for diagnostic purposes, it remains integral to endovascular procedures, during which it guides catheter navigation and device deployment in real time.

---

Prognosis

When an aortic aneurysm is diagnosed in time (before rupture or dissection), it can be managed effectively through a combination of:

• Pharmacological risk factor modification
• Regular surveillance imaging to monitor aneurysm growth
• Elective surgical repair when size or growth rate thresholds are reached

The prognosis for elective (planned) surgical repair of an aortic aneurysm, whether by open surgery or endovascular technique, is generally good. Mortality rates at experienced centers are 1–3% for elective endovascular AAA repair and 3–5% for open surgical repair. Outcomes are substantially better when surgery is performed before the aneurysm ruptures.

In contrast, the prognosis for ruptured AAA is catastrophic:

• The overall mortality of ruptured AAA (including patients who die before reaching the hospital) is approximately 80–90%.
• Of those who reach the hospital alive and undergo emergency surgery, operative mortality is approximately 40–50%.
• Only approximately 1 in 5 patients with a ruptured AAA ultimately survives.

This dramatic difference in survival between elective repair (low mortality) and ruptured repair (very high mortality) provides the strongest possible argument for early detection through screening and elective repair before rupture occurs.

Untreated aortic aneurysms grow progressively. The rate of growth is variable but averages approximately 2–4 mm per year for AAA, with faster growth in larger aneurysms, smokers, and those with poorly controlled hypertension. As the aneurysm enlarges, the risk of rupture increases, most significantly for AAAs exceeding 5.5 cm in maximum diameter.

---

Treatment

Aortic aneurysms are managed through a combination of pharmacological therapy, regular surveillance, and surgical intervention. The appropriate treatment strategy depends primarily on:

• Aneurysm size and location
• Rate of growth
• Presence or absence of symptoms
• Patient age, comorbidities, and surgical risk
• Anatomical suitability for endovascular repair

Small, asymptomatic aneurysms discovered at an early stage may require no immediate intervention, only regular monitoring. For AAAs less than 5 cm in maximum diameter, surveillance imaging (typically ultrasound every 6–12 months) without surgery is generally the appropriate strategy in asymptomatic patients, as the annual rupture risk below this threshold is low.

The frequency of surveillance imaging depends on aneurysm size:

• Small AAA (3.0–4.4 cm): Annual ultrasound
• Medium AAA (4.5–5.4 cm): Every 6 months
• Large AAA (≥5.5 cm): Surgical repair is generally indicated in fit patients

Surgical repair is recommended when:

• The maximum diameter reaches or exceeds 5.5 cm in men (or approximately 5.0–5.2 cm in women, who have higher rupture risk at smaller diameters)
• Growth exceeds 1 cm per year regardless of absolute size
• The aneurysm becomes symptomatic (pain, tenderness)
• There is evidence of impending rupture or dissection

Medications

Medical therapy is used to modify risk factors and slow aneurysm progression, rather than to treat the aneurysm directly. No medication has been proven to halt or reverse aneurysm growth, but pharmacological management of modifiable risk factors is essential:

• Beta-blockers: Reduce heart rate and blood pressure, decreasing the mechanical stress (hemodynamic wall stress) imposed on the aortic wall with each heartbeat. Beta-blockers are particularly important in patients with connective tissue disorders (especially Marfan syndrome) and in those with co-existing coronary artery disease.

• Calcium channel blockers: Alternative antihypertensive agents that relax vascular smooth muscle and reduce blood pressure. Used when beta-blockers are contraindicated or insufficient.

• ACE inhibitors and angiotensin receptor blockers (ARBs): These agents, particularly losartan in Marfan syndrome, have been studied for their potential to slow aortic root dilation beyond their blood pressure-lowering effect. While evidence is still evolving, ARBs are commonly prescribed in patients with connective tissue disorders.

• Statins (HMG-CoA reductase inhibitors): Reduce LDL cholesterol and have important anti-inflammatory and plaque-stabilizing effects on the aortic wall beyond lipid lowering. Statin use is associated with reduced AAA growth rate in some observational studies and is recommended for all patients with aortic aneurysms who have atherosclerotic disease.

• Antiplatelet agents (aspirin): Used for cardiovascular risk reduction in patients with concurrent atherosclerotic disease.

The overarching pharmacological principle is strict blood pressure control, targeting systolic blood pressure well below 130 mmHg, combined with cholesterol management and smoking cessation to minimize the mechanical and inflammatory forces driving aneurysm progression.

Surgical Intervention

Surgery is indicated when the aneurysm reaches a size at which the risk of rupture outweighs the risk of operative repair, or when symptoms develop. Two main surgical approaches are available:

Open Surgical Repair (Abdominale or Thoracic)

Open repair is the traditional surgical gold standard for aortic aneurysms. The procedure is performed under general anesthesia. The patient is placed in a state of deep, controlled unconsciousness for the duration of the operation.

The surgeon makes a large incision in the abdomen (for AAA) or chest (for TAA) to directly access the aorta. The aneurysmal segment is opened, any clot inside is removed, and the weakened or diseased aortic wall is replaced with a synthetic graft made from prosthetic materials, most commonly Dacron® (polyester) or ePTFE (Teflon®). These durable materials are sewn into place to restore normal aortic continuity and caliber.

Key procedural characteristics:

• Duration: 3–6 hours, depending on aneurysm extent and complexity
• Hospital stay: 5–8 days post-operatively
• Recovery time: Approximately 1 month before returning to normal daily activities; full physical recovery may take several months
• Concurrent procedures: If aortic valve repair or replacement is needed (as in patients with significant aortic regurgitation associated with ascending aortic aneurysm), it can be performed simultaneously during open chest surgery
• Long-term durability: Excellent. Open surgical repair is highly durable, with few late complications and no requirement for routine surveillance of the graft itself over time.
• Most patients achieve complete recovery after open repair

Open repair remains the treatment of choice for aneurysms that are not anatomically suitable for endovascular repair, for younger patients with long life expectancy, and for complex aneurysm configurations.

Endovascular Aneurysm Repair (EVAR / TEVAR)

Endovascular repair represents a major technological advance in vascular surgery that has transformed the management of aortic aneurysms in the past three decades. In endovascular repair, the aneurysm is not surgically removed. Instead, the aneurysm is effectively excluded from the circulation by inserting a stent-graft (also called an endoprosthesis or endograft) from within the arterial lumen.

The procedure is performed under general or regional anesthesia. The steps are:

1. The surgeon makes small incisions in the groins (or uses percutaneous access) to introduce flexible catheters into the femoral arteries.
2. Using real-time fluoroscopic X-ray guidance, the catheters are advanced up through the arterial system to the level of the aneurysm.
3. The stent-graft, a compressed metallic wire framework covered with a synthetic fabric sleeve, is delivered to the target location inside the aneurysm through the catheter.
4. The stent-graft is deployed (expanded) at the landing zones above and below the aneurysm, where the aorta has normal caliber, sealing the aneurysm sac from blood flow.
5. The graft creates a new, stable conduit for blood flow, bypassing the weakened aneurysmal wall. Excluded from the circulation, the aneurysm sac gradually thromboses and may shrink over time.

Advantages of endovascular repair:

• Significantly shorter recovery time compared to open surgery; patients typically leave hospital in 1–3 days and return to normal activities within 2 weeks
• Smaller incisions, less trauma, less blood loss
• Suitable for higher-risk patients who could not tolerate open surgery
• Lower short-term mortality and complication rates compared to open surgery

Limitations and disadvantages:

• Not all aneurysms are anatomically suitable for endovascular repair. The size, shape, and location of the aneurysm (particularly the anatomy of the aortic neck above the aneurysm and the iliac arteries below) must be compatible with currently available stent-graft designs.
• Long-term follow-up with imaging is required: unlike open repair, endovascular repair requires regular surveillance CT or ultrasound (typically annually for life) to detect potential late complications.
  • Endoleaks: Persistent blood flow into the aneurysm sac outside the stent-graft, which can maintain pressurization of the sac and risk of growth and rupture
  • Stent-graft migration: Displacement of the device from its original position
  • Graft limb thrombosis: Clotting within a limb of the graft
  • Structural failure of the graft
• Some patients require secondary interventions to address endoleaks or other complications
• Long-term durability data are still accumulating relative to the multi-decade data available for open repair

The choice between open and endovascular repair is individualized based on aneurysm anatomy, patient age and physiological fitness, institutional expertise, and patient preference. This decision is made in close collaboration between the patient and the vascular surgical team.

Living with an Aneurysm

If you have been diagnosed with an aortic aneurysm, strict adherence to your treatment plan and ongoing medical follow-up are essential to prevent the catastrophic complications of rupture and dissection.

Practical recommendations for daily living include:

• Follow all medical appointments and surveillance imaging: The monitoring schedule recommended by your physician, whether every few months or annually, is designed to detect aneurysm growth before it reaches dangerous dimensions. Never skip these appointments.

• Adhere strictly to prescribed medications: Blood pressure control is critical. Take all medications exactly as prescribed, without interruption.

• Avoid heavy lifting and extreme physical exertion: Lifting heavy weights or performing Valsalva maneuvers (straining against a closed airway) transiently raises blood pressure dramatically, potentially increasing the stress on the aneurysm wall. Your physician will advise on safe activity limits for your specific situation.

  • If heavy lifting is part of your occupation, discuss this openly with your physician and vascular surgeon; occupational modification may be recommended.

• Avoid emotional situations that cause intense stress: Strong emotional arousal (anger, fright, extreme excitement) can cause acute surges in blood pressure. While unavoidable in daily life, awareness of this risk is important, particularly with larger aneurysms.

• Do not ignore new symptoms: Any new onset of back pain, abdominal pain, or chest pain, even if mild, should be promptly reported to your physician. The development of new symptoms in a known aneurysm patient requires urgent reassessment.

• Recognize emergency warning signs: Know the symptoms of rupture and dissection (sudden, severe, unexplained abdominal or back pain, with or without collapse and sweating) and have a clear plan for emergency response, including who to call and which hospital to go to.

• Inform all healthcare providers of your diagnosis: Including dentists, anesthesiologists, and emergency physicians. The diagnosis may influence decisions about blood pressure management, anticoagulation, and anesthesia planning.

---

Prevention

The most effective strategy to reduce the risk of developing an aortic aneurysm is to minimize modifiable risk factors through healthy lifestyle choices and management of underlying conditions. Not all risk factors are controllable, but a substantial proportion of aneurysm risk is lifestyle-attributable and therefore preventable.

Smoking cessation is the single most important preventive measure for AAA. If you smoke:

• Quitting smoking is the most impactful step you can take to reduce your aneurysm risk and your overall cardiovascular risk.
• Your physician can recommend evidence-based cessation programs, nicotine replacement therapies, and pharmacological support (such as varenicline or bupropion) to help you quit.
• Avoid passive smoking as well, since secondhand smoke exposure also has cardiovascular consequences.

Maintain a heart-healthy diet:

• Base your diet on abundant fruits and vegetables, whole grains, legumes, fish, lean poultry, and low-fat dairy products
• Limit saturated and trans fats, excess sodium (salt), and added sugars
• A dietary pattern consistent with the Mediterranean diet is associated with reduced cardiovascular risk across multiple endpoints, including atherosclerotic disease

Stay physically active:

• Regular physical activity of moderate intensity (such as walking, swimming, or cycling) is recommended for cardiovascular health
• Discuss with your physician the types and intensity of exercise appropriate for your specific health status

Control blood pressure:

• Arterial hypertension (high blood pressure) is both a risk factor for aneurysm development and a driver of aneurysm growth. Blood pressure should be maintained within normal limits through lifestyle modification and, when necessary, pharmacological treatment.
• Home blood pressure monitoring and regular follow-up with your physician are recommended.

Control cholesterol:

• Elevated LDL cholesterol promotes atherosclerosis, which underlies most AAA. Dietary modification and statin therapy (when indicated) are important.

Manage diabetes:

• Poorly controlled diabetes accelerates atherosclerotic disease and vascular aging.

Screening for Aneurysms

While an aortic aneurysm cannot always be prevented, particularly when it arises from genetic or constitutional factors, early detection through targeted screening can identify aneurysms before they rupture. This enables planned elective repair when it carries low operative risk.

Because aneurysms can grow for years without symptoms, screening of high-risk individuals is strongly recommended even in the absence of symptoms.

Established screening indications include:

• Men aged 65–75 who have ever smoked (≥100 cigarettes lifetime): One-time abdominal ultrasound screening for AAA is recommended by major international guidelines (USPSTF, ESC, SVS). The benefit in this group is well established: screening reduces AAA-related mortality by approximately 43% through timely detection and intervention.

• First-degree relatives of patients with AAA: Screening ultrasound is recommended for siblings (particularly brothers) of patients with known AAA, starting at age 60.

• Patients with known genetic syndromes predisposing to aortic aneurysm (Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, bicuspid aortic valve, etc.): Annual or biannual echocardiography and/or CTA/MRI of the aorta, beginning in young adulthood (the specific protocol depends on the syndrome and the patient’s aortic diameter trajectory).

• Patients with other peripheral artery aneurysms (popliteal, femoral): Abdominal ultrasound screening for concomitant AAA.

For individuals at known high risk, whether from family history, genetic syndromes, or personal cardiovascular history, periodic screening imaging (abdominal ultrasound for AAA; echocardiography or CTA for TAA) is a straightforward, non-invasive, and cost-effective strategy that can be truly life-saving.

---

Sources and Bibliography

• National Heart, Lung, and Blood Institute (NHLBI). “Aortic Aneurysm”. U.S. Department of Health and Human Services. https://www.nhlbi.nih.gov/health/aortic-aneurysm
• Chaikof, E. L., et al. (2018). “The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm”. Journal of Vascular Surgery, 67(1), 2–77. https://doi.org/10.1016/j.jvs.2017.10.044
• Erbel, R., et al. (2014). “2014 ESC Guidelines on the diagnosis and treatment of aortic diseases”. European Heart Journal, 35(41), 2873–2926. https://doi.org/10.1093/eurheartj/ehu281
• U.S. Preventive Services Task Force (USPSTF). “Abdominal Aortic Aneurysm: Screening”. JAMA, 2019;322(22):2211–2218. https://doi.org/10.1001/jama.2019.18928
• Nordon, I. M., et al. (2011). “Pathophysiology and epidemiology of abdominal aortic aneurysms”. Nature Reviews Cardiology, 8(2), 92–102. https://doi.org/10.1038/nrcardio.2010.180
• Kent, K. C. (2014). “Abdominal aortic aneurysms”. New England Journal of Medicine, 371(22), 2101–2108. https://doi.org/10.1056/NEJMcp1401430
• Baumgartner, H., et al. (2017). “2017 ESC/EACTS Guidelines for the management of valvular heart disease”. European Heart Journal, 38(36), 2739–2791. https://doi.org/10.1093/eurheartj/ehx391
• Lovegrove, R. E., et al. (2008). “A meta-analysis of 21,178 patients undergoing open or endovascular repair of abdominal aortic aneurysm”. British Journal of Surgery, 95(6), 677–684. https://doi.org/10.1002/bjs.6252
• Isselbacher, E. M., et al. (2022). “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease”. Journal of the American College of Cardiology, 80(24), e223–e393. https://doi.org/10.1016/j.jacc.2022.08.004
• MedlinePlus. “Aortic aneurysm”. U.S. National Library of Medicine. https://medlineplus.gov/aorticaneurysm.html
• Kuivaniemi, H., & Tromp, G. (2015). “Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases”. Gene, 707, 151–171. https://doi.org/10.1016/j.gene.2019.05.003
• Loeys, B. L., et al. (2010). “The revised Ghent nosology for the Marfan syndrome”. Journal of Medical Genetics, 47(7), 476–485. https://doi.org/10.1136/jmg.2009.072785